URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Sharon Elad

Concepts (398)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hematopoietic Stem Cell Transplantation
25
1997
133
7.000
Why?
Graft vs Host Disease
24
1997
95
6.370
Why?
Mouth Diseases
12
1999
47
6.330
Why?
Diphosphonates
11
2006
41
5.390
Why?
Osteonecrosis
11
2006
24
4.610
Why?
Dental Care for Chronically Ill
12
1997
17
4.420
Why?
Jaw Diseases
9
2006
15
4.230
Why?
Mouth Mucosa
14
1997
44
3.580
Why?
Bone Density Conservation Agents
7
2007
49
3.520
Why?
Immunosuppressive Agents
10
1997
206
2.540
Why?
Antibiotic Prophylaxis
5
2007
34
2.380
Why?
Stomatitis
6
1997
16
2.150
Why?
Budesonide
3
2003
10
1.930
Why?
Jaw
3
2006
12
1.890
Why?
Mouthwashes
6
1999
31
1.860
Why?
Mouth Neoplasms
5
2007
34
1.790
Why?
Middle Aged
40
1996
10013
1.640
Why?
Humans
83
1993
37165
1.600
Why?
Dental Care
6
2002
46
1.490
Why?
Endocarditis, Bacterial
3
2007
32
1.450
Why?
Practice Guidelines as Topic
8
2006
319
1.380
Why?
Mucositis
4
2006
14
1.280
Why?
Transplantation Conditioning
7
2003
36
1.280
Why?
Male
46
1996
20139
1.200
Why?
Osteomyelitis
2
2006
44
1.190
Why?
American Heart Association
3
2007
24
1.120
Why?
Female
43
1996
20222
1.080
Why?
Pilot Projects
10
1997
446
1.080
Why?
Carcinoma, Squamous Cell
4
2007
238
1.020
Why?
Chronic Disease
11
1997
554
1.010
Why?
Adult
35
1993
11572
0.970
Why?
Anesthetics, Local
3
1999
84
0.970
Why?
Phototherapy
2
2008
18
0.940
Why?
Emergencies
6
2002
83
0.920
Why?
Oral Surgical Procedures
3
2008
10
0.900
Why?
Treatment Outcome
17
1996
2671
0.880
Why?
Administration, Topical
8
1997
91
0.880
Why?
Head and Neck Neoplasms
3
2007
84
0.880
Why?
Antineoplastic Agents, Alkylating
2
2005
44
0.860
Why?
Paraneoplastic Syndromes
3
2007
12
0.850
Why?
Lymphoma, Non-Hodgkin
2
2009
113
0.830
Why?
Antimicrobial Cationic Peptides
1
2011
13
0.830
Why?
Aged
22
2003
7392
0.810
Why?
Anticoagulants
3
1996
141
0.810
Why?
Anti-Infective Agents
2
2006
78
0.810
Why?
Platelet Aggregation Inhibitors
2
2008
60
0.810
Why?
Endocarditis
1
2011
11
0.800
Why?
Tacrolimus
3
2003
69
0.790
Why?
Drug Discovery
1
2011
11
0.780
Why?
Stroke
3
2004
138
0.780
Why?
Calcineurin
1
2010
25
0.770
Why?
Cyclophosphamide
2
2006
177
0.760
Why?
Toothache
1
2010
9
0.760
Why?
Anesthesia, Dental
2
2002
14
0.760
Why?
Osteoporosis
2
2007
83
0.750
Why?
Neurotoxicity Syndromes
1
2010
15
0.750
Why?
Immunocompromised Host
2
2007
85
0.740
Why?
Immunoglobulin Light Chains
1
2010
20
0.740
Why?
Facial Pain
2
2007
48
0.740
Why?
Multiple Myeloma
2
2006
75
0.740
Why?
Amyloid
1
2010
20
0.730
Why?
Heparin, Low-Molecular-Weight
2
1996
16
0.730
Why?
Amyloidosis
1
2010
29
0.730
Why?
Immunologic Factors
1
2011
72
0.730
Why?
Anti-Inflammatory Agents
4
2003
115
0.730
Why?
Bone Marrow Transplantation
7
1996
201
0.730
Why?
Herpesviridae Infections
1
2010
71
0.720
Why?
Blood Pressure
3
2002
468
0.720
Why?
Oral Medicine
1
2009
2
0.720
Why?
Neoplasm Recurrence, Local
2
1997
295
0.720
Why?
Stem Cell Transplantation
2
2005
115
0.710
Why?
Clinical Governance
1
2009
1
0.700
Why?
Patient Acceptance of Health Care
1
2011
123
0.700
Why?
Vasoconstrictor Agents
2
2002
31
0.680
Why?
Opportunistic Infections
1
2008
20
0.670
Why?
Pemphigus
1
2008
8
0.660
Why?
Antiviral Agents
1
2010
170
0.660
Why?
Root Planing
1
2008
13
0.650
Why?
Gingival Hemorrhage
1
2008
35
0.650
Why?
Shock
1
2008
21
0.650
Why?
Diabetes Mellitus, Type 2
3
2006
222
0.650
Why?
Antineoplastic Combined Chemotherapy Protocols
4
1997
436
0.650
Why?
Neoplasms
4
2003
743
0.650
Why?
Gingival Diseases
1
2008
9
0.640
Why?
Leukoplakia, Oral
1
2007
1
0.640
Why?
Pain
2
2003
392
0.630
Why?
Periodontitis
1
2008
61
0.630
Why?
Lymphoproliferative Disorders
1
2008
30
0.630
Why?
Diabetes Complications
1
2008
66
0.620
Why?
Dental Implantation, Endosseous
1
2008
45
0.620
Why?
Precancerous Conditions
1
2007
45
0.610
Why?
Double-Blind Method
5
2006
996
0.610
Why?
Periodontal Diseases
2
2007
74
0.610
Why?
Antineoplastic Agents
3
2006
628
0.600
Why?
Xerostomia
4
2006
44
0.600
Why?
Myocardial Ischemia
1
2008
120
0.600
Why?
Hematologic Diseases
1
2007
40
0.590
Why?
Terfenadine
1
2006
3
0.590
Why?
Loratadine
1
2006
2
0.590
Why?
Rhinitis
1
2006
7
0.580
Why?
Saliva
2
2006
223
0.580
Why?
Candidiasis, Oral
1
2006
24
0.570
Why?
Chlorhexidine
1
2006
28
0.570
Why?
Amphotericin B
1
2006
26
0.570
Why?
Histamine
1
2006
20
0.570
Why?
Decision Support Techniques
1
2007
75
0.560
Why?
Gels
1
2006
49
0.560
Why?
Salivary Glands
1
2006
66
0.560
Why?
Severity of Illness Index
2
2009
943
0.550
Why?
Risk Factors
9
1993
2331
0.550
Why?
Heart Rate
1
2008
457
0.540
Why?
Antifungal Agents
1
2006
60
0.540
Why?
Prospective Studies
7
2006
1696
0.530
Why?
Young Adult
7
2009
1084
0.530
Why?
Research Design
1
2008
340
0.530
Why?
Placebos
3
2006
185
0.520
Why?
United States
6
2007
2847
0.510
Why?
Risk Assessment
4
2007
875
0.500
Why?
Lidocaine
2
1999
76
0.480
Why?
Infection Control, Dental
1
2003
1
0.470
Why?
Smoking
2
2007
423
0.470
Why?
Laser Therapy
1
2003
63
0.460
Why?
Ultraviolet Therapy
2
1998
6
0.450
Why?
Burning Mouth Syndrome
1
2002
5
0.430
Why?
Adolescent
12
1993
5044
0.420
Why?
Dental Materials
1
2002
26
0.420
Why?
Skin Diseases
1
2003
121
0.410
Why?
Drug Hypersensitivity
1
2002
44
0.410
Why?
Electric Stimulation Therapy
2
2011
29
0.400
Why?
Questionnaires
4
2007
1061
0.400
Why?
Clinical Protocols
3
2007
107
0.390
Why?
Vidarabine
3
2003
28
0.380
Why?
Carotid Stenosis
3
2004
52
0.360
Why?
Adrenal Cortex Hormones
3
2008
99
0.360
Why?
Myeloablative Agonists
2
2006
6
0.360
Why?
Time Factors
7
1996
3234
0.350
Why?
Oral Ulcer
2
2008
8
0.350
Why?
Early Diagnosis
2
2007
29
0.340
Why?
Follow-Up Studies
5
2004
1889
0.340
Why?
Ischemic Attack, Transient
3
2002
40
0.330
Why?
Aged, 80 and over
4
2006
2588
0.330
Why?
Pain Measurement
2
2009
248
0.330
Why?
Statistics, Nonparametric
2
2007
269
0.320
Why?
Transplantation, Homologous
9
1997
280
0.320
Why?
Great Britain
2
2007
100
0.320
Why?
Thalidomide
1
1997
14
0.310
Why?
Sensation Disorders
1
1997
17
0.310
Why?
Mouth
1
1997
57
0.310
Why?
Hepatic Veno-Occlusive Disease
2
1993
3
0.300
Why?
Carotid Artery, Internal
3
2004
31
0.290
Why?
Peripheral Nervous System Diseases
1
1997
104
0.280
Why?
Leukemia, Myeloid, Acute
2
2007
183
0.280
Why?
Child
10
1997
4342
0.270
Why?
Anesthesia, Local
2
2002
21
0.270
Why?
Retrospective Studies
4
2004
2302
0.260
Why?
Cyclosporine
3
2003
66
0.260
Why?
Peripheral Blood Stem Cell Transplantation
2
2003
21
0.250
Why?
Israel
3
2002
31
0.250
Why?
Quality of Life
2
2007
528
0.250
Why?
Busulfan
4
2003
13
0.230
Why?
Case-Control Studies
2
1999
624
0.230
Why?
Glucocorticoids
3
2008
168
0.230
Why?
Chi-Square Distribution
2
2011
347
0.230
Why?
Cohort Studies
2
2006
984
0.220
Why?
Lingual Nerve
1
2012
8
0.220
Why?
Neutropenia
2
2009
70
0.220
Why?
Standard of Care
1
2012
4
0.220
Why?
Therapy, Computer-Assisted
1
2012
13
0.210
Why?
Dental Offices
2
2002
4
0.210
Why?
Bacterial Load
1
2011
2
0.210
Why?
Bacteria, Anaerobic
1
2011
7
0.210
Why?
Bacteria, Aerobic
1
2011
7
0.210
Why?
Hematologic Neoplasms
3
2004
34
0.210
Why?
Viridans Streptococci
1
2011
3
0.210
Why?
Staphylococcus
1
2011
12
0.210
Why?
Gram-Negative Bacteria
1
2011
21
0.210
Why?
Yeasts
1
2011
30
0.210
Why?
Tablets
1
2011
7
0.200
Why?
Streptococcus
1
2011
80
0.200
Why?
Safety
1
2011
106
0.200
Why?
Prosthesis-Related Infections
1
2011
11
0.200
Why?
Lichen Planus, Oral
1
2011
1
0.200
Why?
Stomatitis, Aphthous
1
2011
7
0.200
Why?
Tetracyclines
1
2011
7
0.200
Why?
Bone Diseases, Metabolic
1
2011
22
0.200
Why?
Sjogren's Syndrome
1
2011
19
0.190
Why?
Retinoids
1
2011
25
0.190
Why?
Drug Design
1
2010
45
0.190
Why?
Dental Pulp
1
2010
15
0.190
Why?
Radiography, Panoramic
3
2004
17
0.190
Why?
Epithelium
1
2011
231
0.190
Why?
Antibodies, Monoclonal
3
2006
748
0.190
Why?
Gaucher Disease
1
2010
6
0.190
Why?
Societies, Dental
1
2010
5
0.190
Why?
Drug Administration Schedule
1
2011
374
0.180
Why?
Neoplasms, Second Primary
2
2008
125
0.180
Why?
Herpes Simplex
1
2010
47
0.180
Why?
Mandibular Diseases
1
2009
19
0.180
Why?
Light
1
2010
157
0.180
Why?
Wound Healing
2
2008
213
0.180
Why?
Virus Diseases
1
2010
73
0.180
Why?
Health Surveys
1
2010
234
0.180
Why?
Myelodysplastic Syndromes
2
2007
132
0.180
Why?
Speech Disorders
2
2003
17
0.180
Why?
Clinical Trials as Topic
2
2006
685
0.170
Why?
National Institutes of Health (U.S.)
1
2009
64
0.170
Why?
Antihypertensive Agents
1
2010
83
0.170
Why?
American Hospital Association
1
2008
3
0.170
Why?
Lichenoid Eruptions
1
2008
1
0.170
Why?
Administration, Buccal
1
2008
3
0.170
Why?
Dentist's Practice Patterns
1
2008
6
0.170
Why?
Statistics as Topic
1
2009
189
0.170
Why?
Diabetes Mellitus
2
2002
168
0.170
Why?
Dermatologic Agents
1
2009
24
0.170
Why?
Drug Therapy, Combination
2
2006
397
0.170
Why?
International Normalized Ratio
1
2008
8
0.170
Why?
Oral Hemorrhage
1
2008
18
0.170
Why?
Carticaine
1
2008
1
0.170
Why?
Lymphoma, B-Cell
1
2009
66
0.170
Why?
Mucocele
1
2008
10
0.170
Why?
Blood Loss, Surgical
1
2008
45
0.160
Why?
Neutrophil Infiltration
1
2008
24
0.160
Why?
Osteoporosis, Postmenopausal
1
2008
16
0.160
Why?
Leukemia, Lymphoid
1
2008
64
0.160
Why?
Ticlopidine
1
2008
6
0.160
Why?
Guideline Adherence
1
2009
87
0.160
Why?
Logistic Models
1
2011
626
0.160
Why?
Erythroplasia
1
2007
1
0.160
Why?
Postoperative Hemorrhage
1
2008
19
0.160
Why?
Tooth Extraction
1
2008
33
0.160
Why?
Epinephrine
1
2008
141
0.160
Why?
Jaw, Edentulous, Partially
2
2004
18
0.160
Why?
Cytodiagnosis
1
2007
33
0.160
Why?
Confounding Factors (Epidemiology)
1
2008
60
0.160
Why?
Drug Combinations
1
2008
150
0.160
Why?
Aspirin
1
2008
59
0.160
Why?
World Health Organization
1
2008
41
0.160
Why?
Pain, Referred
1
2007
3
0.160
Why?
Infusions, Intravenous
1
2008
143
0.150
Why?
Fatal Outcome
1
2008
109
0.150
Why?
Herpesvirus 4, Human
1
2008
66
0.150
Why?
Observer Variation
1
2008
146
0.150
Why?
Trigeminal Neuralgia
1
2007
12
0.150
Why?
Trigeminal Nerve
1
2007
19
0.150
Why?
Bone Marrow
1
2009
292
0.150
Why?
Lymphoma, Follicular
1
2008
61
0.150
Why?
Diagnosis, Differential
1
2010
889
0.150
Why?
Recombinant Fusion Proteins
1
2009
392
0.150
Why?
Tomography, X-Ray Computed
2
2003
785
0.150
Why?
Immunosuppression
1
2007
68
0.150
Why?
Histamine H1 Antagonists, Non-Sedating
1
2006
1
0.150
Why?
Fanconi Anemia
1
2006
3
0.150
Why?
Necrosis
1
2006
103
0.140
Why?
Stress, Psychological
1
2010
290
0.140
Why?
Cardiovascular Diseases
1
2010
275
0.140
Why?
Gastrointestinal Diseases
1
2006
35
0.140
Why?
Societies, Medical
1
2007
142
0.140
Why?
Disease Models, Animal
2
2006
974
0.140
Why?
Random Allocation
1
2006
253
0.140
Why?
Analysis of Variance
1
2008
749
0.130
Why?
Haplotypes
1
2005
62
0.130
Why?
Health Knowledge, Attitudes, Practice
1
2008
296
0.130
Why?
Oxygen
1
2008
495
0.130
Why?
Longitudinal Studies
1
2006
413
0.120
Why?
Bronchiolitis Obliterans
1
2003
5
0.120
Why?
Patient Satisfaction
1
2006
243
0.120
Why?
Mediastinal Emphysema
1
2003
9
0.120
Why?
Postoperative Complications
1
2009
764
0.120
Why?
Glycoproteins
1
2005
208
0.120
Why?
Retreatment
1
2003
6
0.120
Why?
Ointments
1
2003
9
0.120
Why?
Nutritional Status
1
2003
44
0.120
Why?
Pain Management
1
2003
51
0.110
Why?
Animals
3
2006
16416
0.110
Why?
Electrocardiography
1
2008
746
0.110
Why?
Peptides
1
2005
293
0.110
Why?
Treatment Failure
1
2003
131
0.110
Why?
Carbon Dioxide
1
2003
213
0.110
Why?
Steroids
1
2003
52
0.110
Why?
Tongue Diseases
1
2002
3
0.110
Why?
Reproducibility of Results
1
2006
903
0.110
Why?
Histamine Release
1
2002
6
0.110
Why?
Health Services Needs and Demand
1
2003
114
0.110
Why?
Endocrine System Diseases
1
2002
13
0.110
Why?
Chest Pain
1
2002
21
0.100
Why?
Postmenopause
1
2002
42
0.100
Why?
Liability, Legal
1
2002
24
0.100
Why?
Respiratory Insufficiency
1
2002
57
0.100
Why?
Syncope
1
2002
99
0.100
Why?
Inflammation
1
2006
544
0.100
Why?
Prevalence
1
2002
582
0.090
Why?
Remission Induction
2
2009
165
0.080
Why?
Antibodies, Monoclonal, Humanized
2
2006
94
0.080
Why?
Fluorescent Antibody Technique
1
1999
307
0.080
Why?
Paresthesia
1
1997
18
0.080
Why?
Hypesthesia
1
1997
12
0.080
Why?
Mastectomy, Segmental
1
1997
25
0.080
Why?
Chemotherapy, Adjuvant
1
1997
88
0.080
Why?
Pulmonary Veno-Occlusive Disease
1
1997
3
0.080
Why?
Tretinoin
1
1997
104
0.070
Why?
Blood Platelet Disorders
1
1996
7
0.070
Why?
Enoxaparin
1
1996
8
0.070
Why?
Hematopoietic Stem Cell Mobilization
2
2003
15
0.070
Why?
Megakaryocytes
1
1996
67
0.070
Why?
Combined Modality Therapy
2
2005
491
0.070
Why?
Fibrinolytic Agents
1
1996
60
0.070
Why?
Anti-Bacterial Agents
2
2009
442
0.070
Why?
Bone Neoplasms
1
1997
208
0.070
Why?
Survival Analysis
2
2005
589
0.070
Why?
Calcinosis
2
2004
62
0.060
Why?
Graft Survival
2
2003
151
0.060
Why?
Secretory Rate
1
2012
43
0.050
Why?
Likelihood Functions
1
2012
54
0.050
Why?
Deglutition Disorders
1
2012
28
0.050
Why?
Selective Estrogen Receptor Modulators
1
2011
9
0.050
Why?
Calcium, Dietary
1
2011
22
0.050
Why?
Hormone Replacement Therapy
1
2011
15
0.050
Why?
Sleep Disorders
1
2012
70
0.050
Why?
Joint Prosthesis
1
2011
25
0.050
Why?
Intention to Treat Analysis
1
2011
10
0.050
Why?
Child, Preschool
2
2006
2737
0.050
Why?
Evidence-Based Dentistry
1
2010
7
0.050
Why?
Bacteremia
1
2011
39
0.050
Why?
Parathyroid Hormone
1
2011
123
0.050
Why?
Breast Neoplasms
1
1997
666
0.050
Why?
Bone Density
1
2011
114
0.050
Why?
Feasibility Studies
2
1996
212
0.050
Why?
Vitamin D
1
2011
71
0.050
Why?
RANK Ligand
1
2011
130
0.050
Why?
Pain, Intractable
1
2010
15
0.050
Why?
Radiation-Protective Agents
1
2010
41
0.050
Why?
Data Collection
1
2011
231
0.040
Why?
Prednisone
1
2010
182
0.040
Why?
Transplantation, Autologous
1
2009
151
0.040
Why?
Chimerism
1
2009
2
0.040
Why?
Histocompatibility
1
2009
14
0.040
Why?
Angiogenesis Inhibitors
1
2009
22
0.040
Why?
Surgical Procedures, Minimally Invasive
1
2009
33
0.040
Why?
Red-Cell Aplasia, Pure
1
2009
9
0.040
Why?
Alendronate
1
2009
26
0.040
Why?
Injections, Intravenous
1
2009
133
0.040
Why?
Dentists
1
2008
17
0.040
Why?
Terminology as Topic
1
2009
108
0.040
Why?
Imidazoles
1
2009
67
0.040
Why?
Immunoglobulins, Intravenous
1
2009
37
0.040
Why?
Antibodies, Monoclonal, Murine-Derived
1
2009
132
0.040
Why?
Radiation Injuries
1
2010
131
0.040
Why?
Administration, Oral
1
2009
314
0.040
Why?
Thrombocytopenia
1
2009
77
0.040
Why?
Dental Caries
1
2010
312
0.040
Why?
Neoadjuvant Therapy
1
2007
32
0.040
Why?
Recurrence
1
2009
697
0.040
Why?
Acute Disease
1
2009
591
0.040
Why?
Histocompatibility Testing
1
2006
38
0.040
Why?
Antilymphocyte Serum
1
2006
26
0.040
Why?
Drug Evaluation
1
2006
99
0.040
Why?
Antibodies, Neoplasm
1
2006
41
0.040
Why?
Curcumin
1
2006
24
0.040
Why?
Dietary Supplements
1
2006
46
0.030
Why?
Medical Oncology
1
2006
49
0.030
Why?
Primary Prevention
1
2006
61
0.030
Why?
Multivariate Analysis
1
2007
548
0.030
Why?
Attitude of Health Personnel
1
2008
302
0.030
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
93
0.030
Why?
Ultrasonography, Doppler, Duplex
1
2004
22
0.030
Why?
Magnetic Resonance Imaging
1
2011
1019
0.030
Why?
Analgesics
1
2006
116
0.030
Why?
Radiotherapy
1
2006
198
0.030
Why?
Evidence-Based Medicine
1
2006
210
0.030
Why?
Endarterectomy, Carotid
1
2004
32
0.030
Why?
Survivors
1
2005
118
0.030
Why?
Nasopharynx
1
2003
47
0.030
Why?
Antigens, CD
1
2005
254
0.030
Why?
Hematopoiesis
1
2004
129
0.030
Why?
Hyperventilation
1
2002
17
0.030
Why?
Hyperthyroidism
1
2002
24
0.030
Why?
Ethics, Dental
1
2002
4
0.030
Why?
Adrenal Insufficiency
1
2002
6
0.030
Why?
Survival Rate
1
2004
619
0.030
Why?
Consciousness
1
2002
22
0.030
Why?
Central Nervous System Depressants
1
2002
10
0.030
Why?
Monitoring, Intraoperative
1
2002
30
0.030
Why?
Angina Pectoris
1
2002
50
0.030
Why?
Documentation
1
2002
37
0.030
Why?
Incidence
1
2004
682
0.030
Why?
Patient Selection
1
2003
223
0.030
Why?
Pulmonary Embolism
1
2002
59
0.030
Why?
Drug Interactions
1
2002
186
0.030
Why?
Hypoglycemia
1
2002
91
0.020
Why?
Respiration
1
2002
181
0.020
Why?
Norepinephrine
1
2002
252
0.020
Why?
Evaluation Studies as Topic
1
1997
247
0.020
Why?
Biological Availability
1
1996
38
0.020
Why?
Platelet Count
1
1996
52
0.020
Why?
Myocardial Infarction
1
2002
651
0.020
Why?
Injections, Subcutaneous
1
1996
93
0.020
Why?
Half-Life
1
1996
104
0.020
Why?
Blood Platelets
1
1996
281
0.010
Why?

Visualizations


Elad's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department